Loading...

The global impact of Precision Medicine Group.
As it happens.

Impact, observations, and insights on the evolving healthcare landscape.

Meeting on the Med 2021 Conference Panel: “Innovation: Shortening the Path to Commercialization in Advanced Therapies”

2021-05-11T17:27:47-04:00Cell & Gene Therapy, Events|

Clare Sarvary Fourrier, SVP of Operational Strategy (EU) for Precision for Medicine moderates this panel discussion with industry experts to share perspectives on the current state of the cell and gene therapy industry and provide key insights in shortening time-to-market for advanced therapies.

(more…)

ASGCT 2021 Conference Panel: Considerations for the Clinical Development of Cell & Gene Therapies Part 2 – Gene Therapy

2021-08-26T16:56:11-04:00Cell & Gene Therapy, Events|

Directly following the cell therapy panel discussion in part 1, Precision experts Phil Cyr, Deb Phippard and David Parker, and Project Pharma’s Tony Khoury joined C-Suite leaders from advanced therapy companies for “Considerations for the Clinical Development of Cell & Gene Therapies.” Part 2- Gene Therapy.

(more…)

ASGCT 2021 Conference Panel: Considerations for the Clinical Development of Cell & Gene Therapies Part 1 – Cell Therapy

2021-08-26T16:48:55-04:00Cell & Gene Therapy, Events|

Miss ASGCT 2021? Check out this cell therapy panel discussion you won’t want to miss! Precision experts David Parker, Alex Grosvenor and Megan Liles, and Project Farma’s John Khoury join biotech executives on the front lines of development for “Considerations for the Clinical Development of Cell & Gene Therapies.” Part 1 – Cell Therapy.

(more…)

Cell and gene therapy: the impact of skills gaps in a fast-growing sector

2021-04-19T17:08:39-04:00Cell & Gene Therapy, Thought Leadership|

The growing skills gaps in cell and gene therapy have resulted in a bottleneck preventing potentially revolutionary treatments from reaching the patients who need them. Phil Massey and Daniel Foody of Project Farma, part of the Precision ADVANCE collective, weigh in on the effects of the talent gap, and discuss strategies for closing the gap.

(more…)

White Paper: Developing Advanced Therapies: Considerations for Internal Versus External Manufacturing

2021-04-01T10:54:58-04:00Cell & Gene Therapy, Thought Leadership|

Due to their complexity and cost, developers of cell and gene therapies face unique manufacturing hurdles. Determining the right approach to manufacturing is crucial when bringing these advanced therapeutics from clinical to commercialization.

This white paper, based on a recent webinar co-sponsored by Precision for Medicine and Informa Pharma Intelligence, features the unique expertise of Erin Harris (Editor In Chief of Cell & Gene), David Carr (Director, PRECISIONadvisors), Tony Khoury (Executive Vice President, Project Farma), Janet Lambert (CEO, Alliance for Regenerative Medicine), and Alex Karnal (Partner and Managing Director, Deerfield Management).

(more…)

Load More Posts